Case number 2017-1560
Merck Sharp & Dohme Corp. v. Amneal Pharmaceuticals LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | MERCK SHARP & DOHME CORP. v. AMNEAL PHARMACEUTICALS LLC [OPINION] [precedential] (0) |
| May 11, 2018 | 56 | Mandate issued to the United States District Court for the District of Delaware. Costs taxed in the amount of $500.00. Service as of this date by the Clerk of Court. [520959] [SJ] [Entered: 05/11/2018 10:04 AM] (1) |
| May 4, 2018 | 55 | ORDER filed denying [50] petition for panel rehearing filed by Merck Sharp & Dohme Corp.; denying [50] petition for en banc rehearing filed by Merck Sharp & Dohme Corp. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [519247] [SJ] [Entered: 05/04/2018 01:03 PM] (2) |
| Apr 19, 2018 | 54 | 18 paper copies of the response [53] received from Appellee Amneal Pharmaceuticals LLC. [515232] [JAB] [Entered: 04/19/2018 11:53 AM] (0) |
| Apr 18, 2018 | 53 | RESPONSE to the petition for panel rehearing [50] filed by Appellant Merck Sharp & Dohme Corp., petition for en banc rehearing [50] filed by Appellant Merck Sharp & Dohme Corp.. Service: 04/18/2018 by email. [514927] [17-1560] [Thomas Meloro] [Entered: 04/18/2018 03:01 PM] (25) |
| Apr 4, 2018 | 52 | The court invites a response from Appellee Amneal Pharmaceuticals LLC to the petition for panel rehearing filed by Appellant in 17-1560, petition for en banc rehearing filed by Appellant in 17-1560. [510503] [SJ] [Entered: 04/04/2018 10:37 AM] (1) |
| Mar 14, 2018 | 51 | 18 paper copies of the petition for panel rehearing [50], petition for en banc rehearing [50] received from Appellant Merck Sharp & Dohme Corp.. [505019] [SJ] [Entered: 03/14/2018 02:12 PM] (0) |
| Mar 12, 2018 | 50 | Petition for panel rehearing, for en banc rehearing filed by Appellant Merck Sharp & Dohme Corp.. Service: 03/12/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 03/14/2018 [504284] [Nicolas Barzoukas] [Entered: 03/12/2018 03:40 PM] (42) |
| Feb 23, 2018 | 49 | Bill of Costs for Appellee Amneal Pharmaceuticals LLC. Service: 02/23/2018 by email. Objection to Bill of Costs due on 03/09/2018. [500808] [Matthew Freimuth] [Entered: 02/23/2018 04:02 PM] (0) |
| Feb 9, 2018 | 48 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (Precedential Opinion). (For the Court: Taranto,Circuit Judge; Clevenger,Circuit Judge and Stoll,Circuit Judge). [496564] [SJ] [Entered: 02/09/2018 09:17 AM] (21) |
| Nov 14, 2017 | 47 | Letter from Appellant Merck Sharp & Dohme Corp. Responding to Amneal's Submission [ECF No. 46]. Service: 11/14/2017 by email. [475370] [Nicolas Barzoukas] [Entered: 11/14/2017 02:14 PM] (4) |
| Nov 13, 2017 | 46 | Letter from Appellee Amneal Pharmaceuticals LLC Submitting Appx300-01 Pursuant to Request of Panel. Service: 11/13/2017 by email. [475039] [Matthew Freimuth] [Entered: 11/13/2017 06:34 PM] (4) |
| Nov 13, 2017 | 45 | Letter from Appellant Merck Sharp & Dohme Corp. Submitting Plaintiff's Trial Exhibit 98 at Request of Panel. Service: 11/13/2017 by email. [474982] [Nicolas Barzoukas] [Entered: 11/13/2017 04:03 PM] (3) |
| Nov 8, 2017 | 44 | Submitted after ORAL ARGUMENT by Nicolas Barzoukas for Merck Sharp & Dohme Corp. and Thomas J. Meloro for Amneal Pharmaceuticals LLC. Panel: Judge: Taranto , Judge: Clevenger , Judge: Stoll. [473960] [JAB] [Entered: 11/08/2017 10:25 AM] (0) |
| Oct 16, 2017 | 43 | Response to oral argument order from the Appellee Amneal Pharmaceuticals LLC. designating Thomas Meloro as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [468130] [Thomas Meloro] [Entered: 10/16/2017 03:26 PM] (0) |
| Oct 6, 2017 | 42 | Response to oral argument order from the Appellant Merck Sharp & Dohme Corp.. designating Nicolas Barzoukas as arguing attorney. Designated time for argument: 10 minutes. Designated time for rebuttal: 5 minutes. Service of other counsel by Notice of Docket Activity from this entry. [466230] [Nicolas Barzoukas] [Entered: 10/06/2017 04:14 PM] (0) |
| Sep 21, 2017 | 41 | NOTICE OF CALENDARING. Panel: 1711G. Case scheduled Nov 08, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 201. Response to oral argument order due: 10/16/2017. Arguing counsel is required to check-in at the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [462656] [JAB] [Entered: 09/21/2017 11:55 AM] (0) |
| May 30, 2017 | 40 | 6 paper copies of the Confidential Joint Appendix [37] received from Appellant Merck Sharp & Dohme Corp. [435388] [KW] [Entered: 05/31/2017 02:39 PM] (0) |
| May 22, 2017 | 39 | Clerk's Note to the File: 6 CD-ROM copies of the Confidential Briefs of the Appellant and Appellee received from Appellant Merck Sharp & Dohme Corp. [433622] [KW] [Entered: 05/23/2017 03:45 PM] (0) |
| May 22, 2017 | 38 | APPENDIX FILED for Merck Sharp & Dohme Corp. [36]. Number of Pages: 290. Service: 05/22/2017 by email. [433388] [JCA] [Entered: 05/23/2017 09:15 AM] (290) |
| May 22, 2017 | 37 | CONFIDENTIAL JOINT APPENDIX FILED for Merck Sharp & Dohme Corp. [35]. Number of Pages: 289. Service: 05/22/2017 by email. The paper copies of the confidential brief should be received by the court on or before 05/31/2017. [433387] [JCA] [Entered: 05/23/2017 09:13 AM] (0) |
| May 22, 2017 | 36 | TENDERED from Appellant Merck Sharp & Dohme Corp. and Appellee Amneal Pharmaceuticals LLC. Title: JOINT APPENDIX. Service: 05/22/2017 by email. [433303] [Nicolas Barzoukas] [Entered: 05/22/2017 05:17 PM] (290) |
| May 22, 2017 | 35 | TENDERED from Appellant Merck Sharp & Dohme Corp. and Appellee Amneal Pharmaceuticals LLC. Title: CONFIDENTIAL JOINT APPENDIX Service: 05/22/2017 by email. [433300] [Nicolas Barzoukas] [Entered: 05/22/2017 05:14 PM] (0) |
| May 22, 2017 | 34 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Merck Sharp & Dohme Corp. and Appellee Amneal Pharmaceuticals LLC. Service: 05/22/2017 by email. [433299] [Joshua Davis] [Entered: 05/22/2017 05:07 PM] (3) |
| May 19, 2017 | 33 | 6 paper copies of the Confidential Reply Brief [31] received from Appellant Merck Sharp & Dohme Corp. [432867] [KW] [Entered: 05/19/2017 02:16 PM] (0) |
| May 15, 2017 | 29 | TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: CONFIDENTIAL REPLY BRIEF Service: 05/15/2017 by email. [431607] [Nicolas Barzoukas] [Entered: 05/15/2017 06:46 PM] (0) |
| May 15, 2017 | 30 | TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: REPLY BRIEF. Service: 05/15/2017 by email. [431608] [Nicolas Barzoukas] [Entered: 05/15/2017 06:48 PM] (42) |
| May 15, 2017 | 31 | CONFIDENTIAL REPLY BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [29]. Number of Pages: 31. Service: 05/15/2017 by email. The paper copies of the confidential brief should be received by the court on or before 05/23/2017. [431683] [JCA] [Entered: 05/16/2017 09:11 AM] (0) |
| May 15, 2017 | 32 | REPLY BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [30]. Number of Pages: 31. Service: 05/15/2017 by email. Appendix is due 05/22/2017. [431685] [JCA] [Entered: 05/16/2017 09:13 AM] (42) |
| May 3, 2017 | 28 | 6 paper copies of the Confidential Response Brief [26] received from Appellee Amneal Pharmaceuticals LLC. [428917] [KW] [Entered: 05/03/2017 02:58 PM] (0) |
| May 1, 2017 | 27 | BRIEF FILED for Appellee Amneal Pharmaceuticals LLC [25]. Number of Pages: 61. Service: 05/01/2017 by email. Appellant Merck Sharp & Dohme Corp. reply brief is due 05/15/2017. [428393] [JCA] [Entered: 05/02/2017 09:20 AM] (76) |
| May 1, 2017 | 26 | CONFIDENTIAL BRIEF FILED for Appellee Amneal Pharmaceuticals LLC [24]. Number of Pages: 61. Service: 05/01/2017 by email. The paper copies of the confidential brief should be received by the court on or before 05/09/2017. [428390] [JCA] [Entered: 05/02/2017 09:19 AM] (0) |
| May 1, 2017 | 25 | TENDERED from Appellee Amneal Pharmaceuticals LLC. Title: RESPONSE BRIEF. Service: 05/01/2017 by email. [428344] [Thomas Meloro] [Entered: 05/01/2017 06:20 PM] (76) |
| May 1, 2017 | 24 | TENDERED from Appellee Amneal Pharmaceuticals LLC. Title: CONFIDENTIAL RESPONSE BRIEF Service: 05/01/2017 by US mail, email. [428343] [Thomas Meloro] [Entered: 05/01/2017 06:16 PM] (0) |
| Apr 26, 2017 | 23 | Notice of intent to file corresponding briefs on CD-ROM for Appellee Amneal Pharmaceuticals LLC. Service: 04/26/2017 by email. [427345] [Matthew Freimuth] [Entered: 04/26/2017 03:24 PM] (3) |
| Apr 20, 2017 | 22 | Entry of appearance for Devon W. Edwards as of counsel for Appellee Amneal Pharmaceuticals LLC. Service: 04/20/2017 by email. [425868] [Devon Edwards] [Entered: 04/20/2017 02:13 PM] (2) |
| Apr 13, 2017 | 21 | Notice of intent to file corresponding briefs on CD-ROM for Appellant Merck Sharp & Dohme Corp.. Service: 04/13/2017 by email. [423872] [Joshua Davis] [Entered: 04/13/2017 03:03 PM] (3) |
| Apr 12, 2017 | 20 | Entry of appearance for Matthew Freimuth as of counsel for Appellee Amneal Pharmaceuticals LLC. Service: 04/12/2017 by email. [423384] [Matthew Freimuth] [Entered: 04/12/2017 11:16 AM] (2) |
| Apr 11, 2017 | 19 | **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [18] filed by Appellee Amneal Pharmaceuticals LLC. Appellee Amneal Pharmaceuticals LLC brief due 05/01/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [423022] [JCA] [Entered: 04/11/2017 08:51 AM] (0) |
| Apr 10, 2017 | 18 | MOTION of Appellee Amneal Pharmaceuticals LLC to extend the time to 05/01/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 04/10/2017 by email. [422953] [Michael Johnson] [Entered: 04/10/2017 05:40 PM] (6) |
| Mar 15, 2017 | 17 | 6 paper copies of the Confidential Opening Brief [14] received from Appellant Merck Sharp & Dohme Corp. [415759] [KW] [Entered: 03/15/2017 03:12 PM] (0) |
| Mar 13, 2017 | 16 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [414687] [JCA] [Entered: 03/13/2017 09:01 AM] (0) |
| Mar 7, 2017 | 15 | BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [13]. Number of Pages: 61. Service: 03/07/2017 by email. Appellee Amneal Pharmaceuticals LLC brief is due 04/17/2017. [413250] [JCA] [Entered: 03/08/2017 09:15 AM] (112) |
| Mar 7, 2017 | 14 | CONFIDENTIAL BRIEF FILED for Appellant Merck Sharp & Dohme Corp. [12]. Number of Pages: 61. Service: 03/07/2017 by email. The paper copies of the confidential brief should be received by the court on or before 03/15/2017. [413245] [JCA] [Entered: 03/08/2017 09:09 AM] (0) |
| Mar 7, 2017 | 13 | TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: OPENING BRIEF. Service: 03/07/2017 by email. [413200] [Nicolas Barzoukas] [Entered: 03/07/2017 06:25 PM] (112) |
| Mar 7, 2017 | 12 | TENDERED from Appellant Merck Sharp & Dohme Corp.. Title: CONFIDENTIAL OPENING BRIEF Service: 03/07/2017 by email. [413199] [Nicolas Barzoukas] [Entered: 03/07/2017 06:22 PM] (0) |
| Feb 15, 2017 | 11 | Certificate of Interest for the Appellee Amneal Pharmaceuticals LLC. Service: 02/15/2017 by email. [407984] [Thomas Meloro] [Entered: 02/15/2017 06:27 PM] (3) |
| Feb 15, 2017 | 10 | Docketing Statement for the Appellee Amneal Pharmaceuticals LLC. Service: 02/15/2017 by email. [407983] [Thomas Meloro] [Entered: 02/15/2017 06:24 PM] (4) |
| Feb 15, 2017 | 9 | Entry of appearance for Michael W. Johnson as of counsel for Appellee Amneal Pharmaceuticals LLC. Service: 02/15/2017 by email. [407981] [Michael Johnson] [Entered: 02/15/2017 06:16 PM] (2) |
| Feb 15, 2017 | 8 | Entry of appearance for Thomas J. Meloro as principal counsel for Appellee Amneal Pharmaceuticals LLC. Service: 02/15/2017 by email. [407979] [Thomas Meloro] [Entered: 02/15/2017 06:08 PM] (2) |
| Feb 14, 2017 | 7 | Entry of appearance for Nicolas Barzoukas as principal counsel for Appellant Merck Sharp & Dohme Corp.. Service: 02/14/2017 by email. [407479] [Nicolas Barzoukas] [Entered: 02/14/2017 06:16 PM] (2) |
| Feb 14, 2017 | 6 | Entry of appearance for Lisa M. Thomas as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 02/14/2017 by email. [407478] [Lisa Thomas] [Entered: 02/14/2017 06:13 PM] (2) |
| Feb 14, 2017 | 5 | Certificate of Interest for the Appellant Merck Sharp & Dohme Corp.. Service: 02/14/2017 by email. [407477] [Joshua Davis] [Entered: 02/14/2017 06:07 PM] (3) |
| Feb 14, 2017 | 4 | Docketing Statement for the Appellant Merck Sharp & Dohme Corp.. Service: 02/14/2017 by email. [407475] [Joshua Davis] [Entered: 02/14/2017 06:04 PM] (3) |
| Feb 14, 2017 | 3 | Entry of appearance for Joshua P. Davis as of counsel for Appellant Merck Sharp & Dohme Corp.. Service: 02/14/2017 by email. [407474] [Joshua Davis] [Entered: 02/14/2017 06:03 PM] (2) |
| Feb 9, 2017 | 2 | Note to file: 17-1560 (COMP COMPANION started 02/09/2017) with 17-1366. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [405989] [17-1366, 17-1560] [JCA] [Entered: 02/09/2017 01:32 PM] (0) |
| Feb 1, 2017 | 1 | Appeal docketed. Received: 02/01/2017. [403771]Entry of Appearance due 02/15/2017. Certificate of Interest is due on 02/15/2017. Docketing Statement due 02/15/2017. Appellant/Petitioner's brief is due 04/03/2017. [JCA] [Entered: 02/01/2017 01:03 PM] (50) |
